Research Article
Interface Hepatitis over Grade 2 May Differentiate Chronic Inflammation Associated with CHB from NAFLD in the Early Stage
Table 1
Baseline characteristics of the participants.
| | | value | NAFLD () | CHB () | CHB and NAFLD () | NAFLD vs. CHB | NAFLD vs. CHB and NAFLD |
| Gender (female/male) | 13/37 | 8/23 | 8/43 | 0.985 | 0.202 | Age | | | | 0.363 | 0.115 | BMI | | | | <0.0001 | <0.0001 | ALT | | | | <0.0001 | <0.0001 | AST | | | | 0.001 | <0.0001 | HBeAg-positive rate | / | 15/31 | 19/51 | 0.321 | / | Hypertension | 7/50 | / | 9/51 | / | 0.616 | Diabetes | 6/50 | / | 6/51 | / | 0.971 | Hyperlipidemia | 46/50 | / | 24/51 | / | <0.0001 | Steatosis | | | | / | <0.0001 | S1 | 17/50 | / | 37/51 | | | S2 | 27/50 | / | 13/51 | | | S3 | 6/50 | / | 1/51 | | |
|
|
NAFLD: nonalcoholic fatty liver disease; CHB: chronic hepatitis B; BMI: body mass index; ALT: alanine aminotransferase; AST: aspartate aminotransferase; HBeAg: HBV e antigen.
|